CA Patent
CA2189542A1 — Alkaline glucose oxidase
Assigned to Novozymes AS · Expires 1995-11-09 · 31y expired
What this patent protects
A glucose oxidase characterized be a pH-optimum in the range pH 6-7, having more than 75% of maximum activity at pH 8, determined at 30°C with d-glucose as substrate.
USPTO Abstract
A glucose oxidase characterized be a pH-optimum in the range pH 6-7, having more than 75% of maximum activity at pH 8, determined at 30°C with d-glucose as substrate.
Drugs covered by this patent
- Ozempic (semaglutide) · Novo Nordisk
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.